ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells Z Ouyang, Q Zhou, WH Wong Proceedings of the National Academy of Sciences 106 (51), 21521-21526, 2009 | 400 | 2009 |
Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity L Liu, C Liu, A Quintero, L Wu, Y Yuan, M Wang, M Cheng, L Leng, L Xu, ... Nature communications 10 (1), 470, 2019 | 197 | 2019 |
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection P Ulz, S Perakis, Q Zhou, T Moser, J Belic, I Lazzeri, A Wölfler, A Zebisch, ... Nature communications 10 (1), 4666, 2019 | 188 | 2019 |
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma P Johnson, Q Zhou, DY Dao, YMD Lo Nature reviews Gastroenterology & hepatology 19 (10), 670-681, 2022 | 139 | 2022 |
Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity C Koch, A Kuske, SA Joosse, G Yigit, G Sflomos, S Thaler, DJ Smit, ... EMBO molecular medicine 12 (9), e11908, 2020 | 98 | 2020 |
Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases L Lin, Y Liu, F Xu, J Huang, TF Daugaard, TS Petersen, B Hansen, L Ye, ... Gigascience 7 (3), giy011, 2018 | 73 | 2018 |
Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review S Han, J Gao, Q Zhou, S Liu, C Wen, X Yang Cancer management and research, 199-206, 2018 | 54 | 2018 |
Long-read sequencing unveils high-resolution HPV integration and its oncogenic progression in cervical cancer L Zhou, Q Qiu, Q Zhou, J Li, M Yu, K Li, L Xu, X Ke, H Xu, B Lu, H Wang, ... Nature communications 13 (1), 2563, 2022 | 49 | 2022 |
Epigenetic analysis of cell-free DNA by fragmentomic profiling Q Zhou, G Kang, P Jiang, R Qiao, WKJ Lam, SCY Yu, MJL Ma, L Ji, ... Proceedings of the National Academy of Sciences 119 (44), e2209852119, 2022 | 35 | 2022 |
Persistence of ctDNA in patients with breast cancer during neoadjuvant treatment is a significant predictor of poor tumor response Q Zhou, SP Gampenrieder, S Frantal, G Rinnerthaler, CF Singer, D Egle, ... Clinical Cancer Research 28 (4), 697-707, 2022 | 33 | 2022 |
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer SO Perakis, S Weber, Q Zhou, R Graf, S Hojas, JM Riedl, A Gerger, ... Esmo Open 5 (5), e000872, 2020 | 30 | 2020 |
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer Q Zhou, SO Perakis, P Ulz, S Mohan, JM Riedl, E Talakic, S Lax, M Tötsch, ... Genome Medicine 12, 1-17, 2020 | 28 | 2020 |
LncRNA TP73‐AS1 predicts poor prognosis and functions as oncogenic lncRNA in osteosarcoma X Chen, Y Zhou, S Liu, D Zhang, X Yang, Q Zhou, Y Song, Y Liu Journal of cellular biochemistry 120 (2), 2569-2575, 2019 | 25 | 2019 |
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology X Zhang, Z Liang, S Wang, S Lu, Y Song, Y Cheng, J Ying, W Liu, Y Hou, ... Cancer biology & medicine 16 (1), 189, 2019 | 24 | 2019 |
Single‐cell RNA‐seq reveals distinct dynamic behavior of sex chromosomes during early human embryogenesis Q Zhou, T Wang, L Leng, W Zheng, J Huang, F Fang, L Yang, F Chen, ... Molecular Reproduction and Development 86 (7), 871-882, 2019 | 23 | 2019 |
Human papillomavirus E7 induces p63 expression to modulate DNA damage response S Eldakhakhny, Q Zhou, EJ Crosbie, BS Sayan Cell Death & Disease 9 (2), 127, 2018 | 23 | 2018 |
Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer X Yang, W Wu, Y Pan, Q Zhou, J Xu, S Han BMC cancer 20, 1-11, 2020 | 22 | 2020 |
The complete and fully-phased diploid genome of a male Han Chinese C Yang, Y Zhou, Y Song, D Wu, Y Zeng, L Nie, P Liu, S Zhang, G Chen, ... Cell Research 33 (10), 745-761, 2023 | 20 | 2023 |
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients C Suppan, R Graf, S Jahn, Q Zhou, EV Klocker, R Bartsch, A Terbuch, ... British Journal of Cancer 126 (3), 456-463, 2022 | 20 | 2022 |
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer T Moser, J Waldispuehl-Geigl, J Belic, S Weber, Q Zhou, ... NPJ Precision Oncology 4 (1), 30, 2020 | 20 | 2020 |